Preview

Russian Journal of Cardiology

Advanced search

APOLIPOPROTEIN A1 GENE AND ITS ROLE IN DYSLIPIDEMIA DEVELOPMENT ACROSS ETHNIC GROUPS OF PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION

Abstract

Aim. To assess the impact of insertion-deletion polymorphism of apolipoprotein A gene on the development of dyslipidemia among adolescents with essential arterial hypertension (EAH), in regard to the ethnic group: non-indigenous Slavic vs. indigenous Buryat. Material and methods. In total, 399 adolescents were examined: 226 patients with the verified EAH diagnosis and 173 controls. Among EAH patients, 144 adolescents (63,7%) were from the non-indigenous ethnic group, while 82 (36,3%) were from the indigenous one; among controls, the respective figures were 94 (53,4%) and 79 (45,7%). Dyslipidemia was diagnosed using the unified criteria. For genetic analyses, total DNA was extracted from venous blood samples, using a non-enzymatic method. DNA fragments were amplified in the polymerase chain reaction (PCR), using the reagent kit “SNP express” according to the producer’s protocol (Litech, Moscow). Results. The deletion allele prevalence in adolescents from the indigenous ethnic group was 8,2% among controls and 8,0% among EAH patients (p=1,000). In the non-indigenous ethnic group, the respective figures were 7,9% and 9,8% (p=0,493). According to the multivariate analysis results, lipid levels in non-indigenous carriers of various insertion-deletion ApoA1 genotypes could be predicted as follows: triglyceride (TG) levels = 1,552 + (-0,653 ApoA1 (II); model F=7,174, p=0,009;  R2=9,4%; very low-density lipoprotein cholesterol (VLD-CH) levels = 0,613 + (-0,189 ApoA1 (II)); model F=4,738, p=0,033; R2=6,3%. Among indigenous patients – carriers of various insertion/deletion ApoA1 genotypes, this polymorphism did not appear to have a significant impact on lipid metabolism parameters. Conclusion. The genome impact on clinical and biochemical phenotype is variable and differs across ethnic groups. Multivariate analyses have demonstrated that TG and VLD-CH levels are associated with the insertion/deletion ApoA1 gene polymorphism. Therefore, this genetic marker could be regarded as a “modifier” gene which determines biochemical polymorphism in non-indigenous patients. In adolescents from the indigenous ethnic group, this molecular and genetic marker appeared irrelevant.

 

 

About the Authors

T. A. Bairova
Research Centre of Family Health and Human Reproduction, Siberian Branch, Russian Academy of Medical Sciences, Irkutsk
Russian Federation


V. V. Dolgikh
Research Centre of Family Health and Human Reproduction, Siberian Branch, Russian Academy of Medical Sciences, Irkutsk
Russian Federation


L. I. Kolesnikova
Research Centre of Family Health and Human Reproduction, Siberian Branch, Russian Academy of Medical Sciences, Irkutsk
Russian Federation


D. M. Munkoeva
Research Centre of Family Health and Human Reproduction, Siberian Branch, Russian Academy of Medical Sciences, Irkutsk
Russian Federation


References

1. Nefedova Zh. V., Soboleva M. K., Kainara V. G. Atherogenous blood potential at children and teenagers with essentsialny arterial hypertension. Actual problems of pediatrics: Materials X-th of the Congr. of Pediatr. of Russia; 2006. p. 414–15. Russian (Нефедова Ж. В., Соболева М. К., Кайнара В. Г. и др. Атерогенный потенциал крови у детей и подростков с эссенциальной артериальной гипертензией. Актуальные проблемы педиатрии: Материалы X Конгресса педиатров России; 2006. 414–5).

2. Denisova D. V. Fifteen-year trends of risk factors of coronary heart disease and a food at teenagers of 14–17 years: Avtoref. diss. …Dr.s of medical sciences. – Novosibirsk, 2009. Russian (Денисова Д. В. Пятнадцатилетние тренды факторов риска ишемической болезни сердца и питания у подростков 14–17 лет: Автореф. дисс. … д-ра мед. наук. Новосибирск, 2009).

3. Ascaso J. F., Fernanadez-Cru A., Gonazlez Santos P. et al. Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum. Am J Cardiovasc Drugs 2004; 4:299–314.

4. Goldschmidt-Clermont P. J., Dong C., Seo D. M. et al. Atherosclerosis, inflammation, genetics, and stem cells: 2012 update. Curr Atheroscler Rep. 2012 Jun;14 (3):201–10.

5. Dawar R., Gurtoo A., Singh. R. Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: a pilot study in a north Indian population. Am J Clin Pathol. 2010; 134 (2):249–55.

6. Miroshnikova V. V., Rodyguna T. I., Demina T. I. Associations of genetic options апопроте-ина A-1 with development of atherosclerosis in inhabitants of St. Petersburg. Ecological genetics 2010; 2:24–8. Russian (Мирошникова В. В., Родыгина Т. И., Демина Е. П. и др. Ассоциации генетических вариантов апопротеина А-1 с развитием атеросклероза у жителей Санкт-Петербурга. Экологическая генетика 2010; 2: 24–8).

7. Padmaja N., Ravindra Kumar M., Adithan C. Association of Polymorphisms in Apolipoprotein A1 and Apolipoprotein B Genes with Lipid Profile in Tamilian Population. Indian Heart J. 2009; 61:51–4.

8. Ali I Albahrani, Jannete Usher J, Mohammed Alkindi et al. ApolipoproteinA1–75 G/A (M1) polymorphism and Lipoprotein (a); Anti- vs. Pro-Atherogenic properties. Lipids in Health and Disease 2007; (6):19.

9. Recommendations about diagnostics, treatment and prevention of arterial hypertension at children and teenagers. J. Pediatr. (Enclosure) 2003; 2. Russian (Рекомендации по диагностике, лечению и профилактике артериальной гипертензии у детей и подростков. Педиатрия (Приложение) 2003).

10. Stoneking N., Fontius J. J., Clifford S. L. et al. Alu insertion polymorphisms and human evolution: evidence for a larger population size in Africa. Genome Res. 1997; 7:1061–71.

11. Stepanov V. A., Charkov V. N., Soltobaeva Zh. O. et al. Υ-хромосомы in population of Central Asia. Genetics 2001; 37 (2):256–9. Russian (Степанов В. А., Харьков В. Н., Солтобаева Ж. О. и др. Гаплотипы Υ-хромосомы в популяции средней Азии. Генетика 2001; 37 (2):256–9).

12. Chitrinskaya Yu. I., Stepanov V. A., Pyzirev V. P. et al. Genetic differentiation of the population of Central Asia according to autosomny markers. Genetics 2003; 39 (10):1389–97. Russian (Хитринская Ю. И., Степанов В. А., Пузырев В. П. и др. Генетическая дифференциация населения Средней Азии по данным аутосомных маркеров. Генетика 2003; 39 (10):1389–97).

13. Kchusainova R. I., Akchmetova V. L., Kukuev I. A. et al. Genetic structure of the people of the Volga-Ural region and Central Asia according to Alu – polymorphism. Genetics 2004; 40 (4):552–9. Russian (Хусаинова Р. И., Ахметова В. Л., Кутуев И. А. Генетическая структура народов Волго-Уральского региона и Средней Азии по данным Alu – полиморфизма. Генетика 2004; 40 (4):552–9).

14. Chitrinskaya Yu. I., Stepanov V. A., Pyzirev V. P. The Alu-polymorphism analysis in the Buryat populations. Genetics 2001; 37 (11): 1553–58. Russian (Хитринская И. Ю., Степанов В. А., Пузырев В. П. Анализ Alu-полиморфизма в бурятских популяциях. Генетика 2001; 37 (11):1553–58).

15. Zalesskii V. N., Velikaya V. N., Dinnik O. B. Molecular mechanisms of nutrient-dependent regulation of an expression of genes and DNA stabilization: bases dietomiki. Russian (Залесский В. Н., Великая Н. В., Дынник О. Б. Молекулярные механизмы нутриентзависимой регуляции экспрессии генов и стабилизации ДНК: основы диетомики). http://www.medved.kiev.ua/arh_nutr/art_2006/n06_1_3. htm (31 May 2012)).


Review

For citations:


Bairova T.A., Dolgikh V.V., Kolesnikova L.I., Munkoeva D.M. APOLIPOPROTEIN A1 GENE AND ITS ROLE IN DYSLIPIDEMIA DEVELOPMENT ACROSS ETHNIC GROUPS OF PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION. Russian Journal of Cardiology. 2012;(6):19-23. (In Russ.)

Views: 561


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)